Cart
sales@molnova.com
Home - Products - PI3K/Akt/mTOR signaling - GSK-3 - GSK3i XIII

GSK3i XIII

CAS No. 404828-08-6

GSK3i XIII( GSK3i-XIII | GSK3iXIII | GSK3 inhibitor XIII )

Catalog No. M24364 CAS No. 404828-08-6

GSK3i XIII is a GSK-3 ATP-binding site inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 130 In Stock
5MG 117 In Stock
10MG 176 In Stock
25MG 295 In Stock
50MG 420 In Stock
100MG 591 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    GSK3i XIII
  • Note
    Research use only, not for human use.
  • Brief Description
    GSK3i XIII is a GSK-3 ATP-binding site inhibitor.
  • Description
    GSK3i XIII is a GSK-3 ATP-binding site inhibitor.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    GSK3i-XIII | GSK3iXIII | GSK3 inhibitor XIII
  • Pathway
    PI3K/Akt/mTOR signaling
  • Target
    GSK-3
  • Recptor
    GSK-3
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    404828-08-6
  • Formula Weight
    301.35
  • Molecular Formula
    C18H15N5
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    CC1=CC(=NN1)NC2=NC(=NC3=CC=CC=C32)C4=CC=CC=C4
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.James TF, Nenov MN, Wildburger NC, Lichti CF, Luisi J, Vergara F, Panova-Electronova NI, Nilsson CL, Rudra JS, Green TA, Labate D, Laezza F. The Nav1.2 channel is regulated by GSK3. Biochim Biophys Acta. 2015 Apr;1850(4):832-44. doi: 10.1016/j.bbagen.2015.01.011. Epub 2015 Jan 20. PubMed PMID: 25615535; PubMed Central PMCID: PMC4336163.
Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • BIP-135

    BIP-135 is a potent and selective ATP-competitive GSK-3 inhibitor. With IC50s of 16 nM and 21 nM for GSK-3α and GSK-3β, respectively. BIP 135 exhibits neuroprotective effect.

  • BRD1652

    BRD1652 is a highly selective, potent, reversible, ATP-competitive GSK3 inhibitor with IC50 of 0.4 nM/4 nM for GSK3α/GSK3β respectively.

  • Aloisine B

    Aloisine B (AloisineB) inhibited cyclin-dependent kinase and glycogen synthase kinase with IC50 values of 0.85 μM and 0.75 μM, respectively.

Sign In Join Free